pneumonia
31.07.2023 | laboratory study
Type I Interferons are Required to Protect Against Bacterial Pneumonia
IFN-I controls MAIT cell functions during K. pneumoniae infection
16.06.2023 | clinical research
Efficacy and Safety of Interferon-Alpha for the Treatment of RSV Pneumonia in Infants
Symptoms resolve much faster
20.10.2022 | clinical research
Interferon-Alpha-2b and Reduning to Treat Viral Pneumonia in Children
Interferon increases the effectiveness of treatment and reduces the symptoms of pneumonia
16.05.2020 | clinical research
China’s successful experience in preventing COVID-19 in non-infected medical stuff
None of the doctors at the Taihe hospital in Shiyan, Hubei province, got the virus within 28 days. 3-level protection: nasal interferon-α2b (4 times a day), thymosin-α1 once a week (subcutaneous)